Recent research reports by analysts who have given permission for publication/listing on this website:

Bioshares Issue 342: Stock Picks - 2010
22/12/2009

Bioshares Issue 337: Starpharma Seeks New Product Opportunity for Vivagel
16/11/2009

Merriman Research Note, 4th August 2009
6/08/2009

Bioshares Issue 322: Biotech Divide Continues
4/08/2009

Bioshares Issue 311: Stellar Performance by Leading Australian Biotech Stocks for Start of 2009
18/05/2009

Merriman Curhan Ford Transitioning Coverage on Starpharma
11/05/2009

Bioshares Issue 280: Starpharma Secures Major Licensing Deal
15/09/2008

Bioshares Issue 265: Starpharma's International Investor Appeal
6/06/2008

Please note that any opinions, estimates or forecasts regarding Starpharma's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Starpharma or its management. Starpharma does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Starpharma cannot guarantee its accuracy.